Patient characteristics
| CoA (n=20) | Controls (n=22) | |
|---|---|---|
| Age (years) | 35±13 | 30±11 |
| Male/female | 16/4 | 14/8 |
| BMI (kg/m2) | 25.0±4.2 | 25.2±5.0 |
| Diabetes (%) | 5 | 0 |
| Hyperlipidaemia (%) | 0 | 0 |
| CAD (%) | 0 | 0 |
| Active smoker (%) | 25.0 | 13.6 |
| Renal insufficiency (%) | 0 | 0 |
| NYHA class (%) | ||
| NYHA class I | 90 | 100 |
| NYHA class II | 10 | 0 |
| NYHA class III | 0 | 0 |
| NYHA class IV | 0 | 0 |
| Age at operation (years) | 7±6 | – |
| Type of operation (%) | ||
| Patch | 35 | – |
| End-to-end anastomosis | 40 | – |
| Interposition of tube graft | 15 | – |
| NA | 10 | – |
| Medication (%) | ||
| ACE-inhibitors | 30 | 0 |
| ARB | 15 | 0 |
| β-blockers | 20 | 0 |
| CCB | 5 | 0 |
| Diuretics | 10 | 0 |
| Statins | 5 | 0 |
ARB, angiotensin receptor blockers; BMI, body mass index; CAD, coronary artery disease; CCB, calcium channel blockers; NA, not available; NYHA, New York Heart Association Functional Classification.